Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Laurent Decosterd

30PUBLICATIONS
105CO-AUTHORS
PharmacogenomicsMicrofluidics and nanofluidicsPharmaceutical delivery technologiesToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

Sort by Publication Date:
|Jun 24, 2026
Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

|Nov 25, 2025
Population Pharmacokinetics of Levosimendan and its Metabolites OR-1855 and OR-1896 in Critically Ill Adults, Neonates and Infants on Veno-Arterial ECMO.

Stéphane Bertin, Monia Guidi, David Haefliger

|Oct 16, 2025
Therapeutic drug monitoring of Janus kinase inhibitors for precision dosing: where do we stand ?

Jérémie Tachet, Catia Marzolini, Laurent A Decosterd

|Sep 09, 2025
Therapeutic Drug Monitoring for Precision Dosing of Janus Kinase Inhibitors: Protocol for a Prospective Observational Study.

Jérémie Tachet, Laurent A Decosterd, Monia Guidi

|May 14, 2025
A Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Cystic Fibrosis Drugs (Caftors) in Plasma and Its Application for Therapeutic Monitoring.

Valentina D'Atri, Fabrizio Corrado, François Versace

|Jan 17, 2025
Individualization of piperacillin dosage based on therapeutic drug monitoring with or without model-informed precision dosing: a scenario analysis.

David Haefliger, Lynn Mina, Monia Guidi

Pageof 5

Frequent Collaborators

12 joint publications

Monia Guidi

9 joint publications

Perrine Courlet

9 joint publications

Catia Marzolini

8 joint publications

Thierry Buclin

8 joint publications

Matthias Cavassini

8 joint publications

Paul Thoueille

7 joint publications

Chantal Csajka

6 joint publications

François R Girardin

3 joint publications

David Haefliger

3 joint publications

Marcel Stoeckle

Frequent Collaborators

12 joint publications

Monia Guidi

9 joint publications

Perrine Courlet

9 joint publications

Catia Marzolini

8 joint publications

Thierry Buclin